2,208
Views
0
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

, , , , , & show all
Pages 2019-2033 | Received 29 Jun 2021, Accepted 13 Aug 2021, Published online: 07 Sep 2021

References

  • goldcopd.org [Internet]. Fontana (WI): Global Initiative for Chronic Obstructive Lung Disease; 2021 [cited 21 April 2021]. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.
  • Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with respimat soft mist inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381–390.
  • Chrystyn H, Small M, Milligan G, et al. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358–365.
  • Hanada S, Wada S, Ohno T, et al. Questionnaire on switching from the tiotropium HandiHaler to the respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J Chron Obstruct Pulmon Dis. 2015;10:69–77.
  • Miravitlles M, Montero-Caballero J, Richard F, et al. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:407–415.
  • Dhand R, Eicher J, Hänsel M, et al. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler. Int J Chron Obstruct Pulmon Dis. 2019;14:509–523.
  • Molimard M, Raherison C, Lignot S, et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2):1601794.
  • Navaie M, Dembek C, Cho-Reyes S, et al. Device use errors with soft mist inhalers: a global systematic literature review and Meta-analysis. Chron Respir Dis. 2020;17:1479973119901234.
  • Gregoriano C, Dieterle T, Breitenstein AL, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237.
  • Gregoriano C, Dieterle T, Breitenstein AL, et al. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respir Res. 2019;20(1):273.
  • Aksu F, Şahin AD, Şengezer T, et al. Effect of training by a physician on dynamics of the use of inhaler devices to improve technique in patients with obstructive lung diseases. Allergy Asthma Proc. 2016;37(5):98–102.
  • Price D, Keininger DL, Viswanad B, et al. Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey. Int J Chron Obstruct Pulmon Dis. 2018;13:695–702.
  • Yawn BP, Mintz ML, Doherty DE. GOLD in practice: Chronic obstructive pulmonary disease treatment and management in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2021;16:289–299.
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50(10):1360–1374.
  • Rau JL. Practical problems with aerosol therapy in COPD. Respir Care. 2006;51(2):158–172.
  • Sanchis J, Corrigan C, Levy ML, ADMIT Group, et al. Inhaler devices - from theory to practice. Respir Med. 2013;107(4):495–502.
  • Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27(6):414–418.
  • Frohnhofen H, Hagen O. Handgrip strength measurement as a predictor for successful dry powder inhaler treatment: application in older individuals with COPD. Z Gerontol Geriatr. 2011;44(4):245–249.
  • Yawn BP, Colice GL, Hodder R. Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis. 2012;7:495–502.
  • Ciciliani AM, Langguth P, Wachtel H. Handling forces for the use of different inhaler devices. Int J Pharm. 2019;560:315–321.
  • Dreher M, Price D, Gardev A, et al. Patient perceptions of the re-usable Respimatt soft mist™ inhaler in current users and those switching to the device: a real-world, non-interventional COPD study. Chron Respir Dis. 2021;18:1479973120986228.
  • Schürmann W, Schmidtmann S, Moroni P, et al. Respimat soft mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med. 2005;4(1):53–61.
  • Dal Negro RW, Povero M. Acceptability and preference of three inhalation devices assessed by the handling questionnaire in asthma and COPD patients. Multidiscip Respir Med. 2016;11(1):7.
  • Hänsel M, Bambach T, Wachtel H. Reduced environmental impact of the reusable Respimat soft mist™ inhaler compared with pressurised metered-dose inhalers. Adv Ther. 2019;36(9):2487–2492.
  • Davis KH, Su J, González JM, et al. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using combivent respimat. Health Qual Life Outcomes. 2017;15(1):201.
  • Ding B, Small M, Scheffel G, et al. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. COPD. 2018;13:927–936.
  • Schreiber J, Sonnenburg T, Luecke E. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates. BMC Pulm Med. 2020;20(1):222.
  • Small M, Anderson P, Vickers A, et al. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Therapy. 2011;28(3):202–212.
  • López-Campos JL, Quintana Gallego E, Carrasco Hernández L. Status of and strategies for improving adherence to COPD treatment. Int J Chron Obstruct Pulmon Dis. 2019;14:1503–1515.
  • Usmani OS. Choosing the right inhaler for your asthma or COPD patient. Ther Clin Risk Manag. 2019;15:461–472.
  • Zhang W, Xu L, Gao S, et al. Technical evaluation of soft mist inhaler use in patients with chronic obstructive pulmonary disease: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2020;15:1471–1479.
  • Darbà J, Ramírez G, Sicras A, et al. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:2335–2345.
  • Kocks JWH, Chrystyn H, van der Palen J, et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim Care Respir Med. 2018;28(1):43.
  • Takemura M, Mitsui K, Itotani R, et al. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:97–104.
  • Luley MC, Loleit T, Knopf E, et al. Training improves the handling of inhaler devices and reduces the severity of symptoms in geriatric patients suffering from chronic-obstructive pulmonary disease. BMC Geriatr. 2020;20(1):398.
  • Press VG, Arora VM, Shah LM, et al. Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012;27(10):1317–1325.
  • Wilson EA, Park DC, Curtis LM, et al. Media and memory: the efficacy of video and print materials for promoting patient education about asthma. Patient Educ Couns. 2010;80(3):393–398.
  • Alsomali HJ, Vines DL, Stein BD, et al. Evaluating the effectiveness of written dry powder inhaler instructions and health literacy in subjects diagnosed with COPD. Respir Care. 2017;62(2):172–178.
  • Braido F, Chrystyn H, Baiardini I, Respiratory Effectiveness Group, et al. “Trying, But Failing” – the role of inhaler technique and mode of delivery in respiratory medication adherence. J Allergy Clin Immunol Pract. 2016;4(5):823–832.